Adverse drug reactions (ADRs) in patients with heart diseases. Comparison between patients without and with heart failure
Author
dc.contributor.author
Ruiz,
Author
dc.contributor.author
Ortiz,
Admission date
dc.date.accessioned
2018-12-20T15:05:08Z
Available date
dc.date.available
2018-12-20T15:05:08Z
Publication date
dc.date.issued
1984
Cita de ítem
dc.identifier.citation
International Journal of Clinical Pharmacology Therapy and Toxicology, Volumen 22, Issue 11, 2018, Pages 595-601
Identifier
dc.identifier.issn
01744879
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/157681
Abstract
dc.description.abstract
Adverse drug reactions (ADRs) may be more frequent in patients who present some diseases. By means of an intensive prospective drug surveillance work, 492 patients with heart diseases, hospitalized at the Department of Medicine of the Clinical Hospital of the University of Chile, were studied in order to determine the frequency and characteristics of ADRs. ADRs were significantly more frequent in patients with heart failure (HF) (30.0%) than in those without HF (22.7%) (p < 0.05). Patients presenting HF developed more metabolic disturbances than patients not presenting HF (p < 0.001). Furosemide was the most frequently used drug in both groups, but treatment with it was longer in patients with HF who presented a significantly higher frequency of adverse reactions to this diuretic (p < 0.05). 89.9% of ADRs in patients without HF and 93.8% of ADRs in those with HF, were dose-related effects. Analyses of some predisposing factors to ADRs, such as age, number of drugs administered, duratio